Cancer Research

February 7, 2014

New direction for treating lung cancer

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

By Leigh MacMillan
December 18, 2013

Targeting tumor “supply lines”

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

By Leigh MacMillan
Andries Zijlstra, Ph.D., and colleagues are studying a biomarker that can help predict prostate cancer recurrance. (photo by Susan Urmy)
December 5, 2013

Predictor of prostate cancer outcomes identified

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.

By VUMC News and Communications
red laser beam
October 17, 2013

New technique tracks breast cancer subtypes, treatment effectiveness

A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days.

By VUMC News and Communications
August 22, 2013

Overcoming resistance in ovarian cancer

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

By Leigh MacMillan
June 10, 2013

Factor’s yin-yang tumor effects

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.

By Leigh MacMillan
September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.
By VUMC News and Communications
1 2 3